Literature DB >> 108464

Galvanized caging as a potential factor in the development of the "fading infant" or "white monkey" syndrome.

D K Obeck.   

Abstract

Four rhesus females and their infants were kept in galvanized enclosures, and three were kept in stainless steel caging. All four offspring in the galvanized enclosures developed achromotrichia, alopecia, and weakness that varied from modererate to severe while the three infants in stainless steel cages were clinically normal. Plasma copper, zinc, and iron values as well as liver copper and zinc values of the infants were compared for the two types of caging. Plasma copper values were significantly lower (p less than 0.001) in the animals housed in galvanized cages. Plasma zinc and liver zinc levels were significantly elevated in these same animals (p less than 0.01 and p less than 0.05, respectively). Significant differences were not detected in liver copper values in the two groups of infants. Copper and zinc levels in the dams' plasma and milk were not statistically different between the two groups.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 108464

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  4 in total

1.  Alopecia induced in young mice by exposure to excess dietary zinc.

Authors:  S A Mulhern; W B Stroube; R M Jacobs
Journal:  Experientia       Date:  1986-05-15

2.  Mortality in captive baboons (Papio spp.): a-23-year study.

Authors:  Edward J Dick; Michael A Owston; John M David; R Mark Sharp; Scott Rouse; Gene B Hubbard
Journal:  J Med Primatol       Date:  2014-02-01       Impact factor: 0.667

3.  White monkey syndrome and presumptive copper deficiency in wild savannah baboons.

Authors:  A Catherine Markham; Laurence R Gesquiere; Jean-Philippe Bellenger; Susan C Alberts; Jeanne Altmann
Journal:  Am J Primatol       Date:  2011-09-06       Impact factor: 2.371

Review 4.  A Literature Review of Unintentional Intoxications of Nonhuman Primates.

Authors:  Jaco Bakker; Arieh Bomzon
Journal:  Animals (Basel)       Date:  2022-03-29       Impact factor: 2.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.